Europe to Spend USD 18 Million in Monkeypox Testing by the End of 2023 - Arizton

09 Feb 2023
www.prnewswire.com
More than 25,300 confirmed Monkeypox cases in Europe (November 2022), the Demand for Monkeypox Testing Tremendously Increasing
CHICAGO, Feb. 9, 2023 /PRNewswire/ -- According to Arizton's latest research report, the Europe monkeypox testing market to spend USD 18 million by the end of 2023. Growing development of rapid testing methods, advancements in PCR technology, and increasing collaborations among the vendors are the growing trends in the market.
Continue Reading
Europe to Spend USD 18 Million in Monkeypox Testing by the End of 2023 - Arizton
Preview
Source: PRNewswire
Europe Monkeypox Testing Market - Industry Outlook and Forecast 2023-2025
There are only a few MPX test kits available in the market. However, governments make efforts to control the virus due to its rapid spread across the region. As case numbers and surveillance measures increase, the MPX testing market is anticipated to grow substantially in the coming months. The Monkeypox outbreak gives companies huge opportunities to develop new diagnostics to detect MPXV. In September 2022, Cosmos Health, a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, over-the-counter (OTC) medications, and medical devices, announced that it entered a contract with Virax Biolabs, a UK-based diagnostics company, focused on the prevention and detection of viral diseases wherein, Virax Biolabs became the distributor of MPXV real-time PCR detection kits. Cosmos Health has exclusive distribution rights for Cyprus and Greece, with the opportunity to distribute test kits across Europe.
Europe Monkeypox Testing Market Report Scope
Click Here to Download the Free Sample Report
Increasing Development by Several vendors is driving the Europe monkeypox testing market growth
In July 2022, ELITechGroup, a France-based privately held manufacturer and distributor of IVD equipment, strategically partnered with Jiangsu Bioperfectus Technologies for monkeypox virus testing across Europe.
In June 2022, Eurobio Scientific launched a CE-marked monkeypox screening test available for hospital use in France.
On 8th June 2022, altona Diagnostics, a medical diagnostic company headquartered in Germany, announced the launch of the RealStar Zoonotic Orthopoxvirus PCR Kit 1.0, a real-time RT-PCR based reagent system for the detection of zoonotic (non-variola) Orthopoxvirus species-specific DNA – including MPVX DNA of the Central and West African strains.
On 27th June 2022, Cepheid collaborated with the UK-based global molecular diagnostics company BioGX and announced a partnership between the two companies to provide a PCR test for MPX that will run on the GeneXpert system.
In July 2022, the altona Diagnostics company launched another monkeypox virus detection kit, Flexstar Monkeypox virus PCR Detection Mix 1.5, for research purposes.
Bioactiva Diagnostica is another Germany-based company that offers PCR kits for monkeypox virus detection.
Europe Monkeypox Testing Market Insights
Syndromic tests for monkeypox detection are expected to witness strong growth because they can distinguish monkeypox from other harmful diseases, allowing for easier treatment. On 25th May 2022, Roche and its subsidiary TIB Molbiol announced that they had developed a unique LightMix Modular Virus kit that simultaneously detects orthopoxvirus and offers information on whether an MPXV is present or not, including all MPXV from both the West African and Central African forms of the virus.
Rapid tests in the Europe monkeypox testing market are also expected to witness strong growth due to their rapid results and increasing consumer preference.
Demand for MPXV testing kits is expected to decline during the forecast as the cases can be seen declining due to increased surveillance, contact tracing, and increasing vaccination across Europe.
Key Company Profiles
Autobio
Applied DNA Sciences
bioactiva diagnostica
CERTEST BIOTEC
CLONIT
FireGene
JOYSBIO (Tianjin) Biotechnology
Nanjing Synthgene Medical Technology
Shanghai Biogerm Medical Technology
Market Segmentation
Type
PCR
Lateral Flow Assay
Others
End-User
Laboratories
Hospitals & Clinics
Others
Region
Europe
EU-5
Spain
France
UK
Germany
Italy
Central, Eastern, and Southern Europe
Netherlands
Portugal
Switzerland
Nordic
Sweden
Denmark
Check Out Some of the Top-Selling Research Related Reports:
In Vitro Diagnostics Market - The global in vitro diagnostics market size crossed USD 105.23 billion in 2022 and is expected to reach USD 127.56 billion by 2028.
HIV Rapid Test Kits Market - The global HIV rapid test kits market size was valued at USD 1.437 billion in 2022 and is expected to reach USD 1.68 billion by 2028.
COVID-19 Rapid Antigen Test Kits Market - The global COVID-19 rapid antigen tests market was valued at USD 4 billion in 2021 and is expected to reach USD 743.07 million by 2027.
Hematology Diagnostics Market - The hematology diagnostics market size was valued at USD 3 billion in 2021 and is expected to reach USD 4 billion by 2027.
Table of Content
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY TYPE
4.3.2 MARKET SEGMENTATION BY END-USER
4.3.3 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 DEVELOPMENT OF RAPID TESTING METHODS
9.2 ADVANCES IN PCR TECHNOLOGY
9.3 VENDOR COLLABORATIONS
10 MARKET GROWTH ENABLERS
10.1 INCREASED GOVERNMENT SURVEILLANCE
10.2 EASE OF REGULATIONS FOR PRODUCT APPROVALS
10.3 INCREASED PRODUCT LAUNCHES
11 MARKET RESTRAINTS
11.1 DECLINE IN MPX CASES
11.2 MPX VACCINE APPROVAL & ACCESS
11.3 FALSE MPX TEST RESULTS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 INSIGHTS BY TYPE
12.1.2 INSIGHTS BY END-USER
12.1.3 INSIGHTS BY GEOGRAPHY
12.2 FIVE FORCES ANALYSIS
12.2.1 THREAT OF NEW ENTRANTS
12.2.2 BARGAINING POWER OF SUPPLIERS
12.2.3 BARGAINING POWER OF BUYERS
12.2.4 THREAT OF SUBSTITUTES
12.2.5 COMPETITIVE RIVALRY
13 TEST TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PCR
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.4 LATERAL FLOW ASSAYS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.5 OTHERS
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
14 END-USER
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 LABORATORIES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.4 HOSPITALS & CLINICS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.5 OTHERS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
15 GEOGRAPHY
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
16 EU-5
16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
16.3 KEY COUNTRIES
16.3.1 SPAIN: MARKET SIZE & FORECAST
16.3.2 FRANCE: MARKET SIZE & FORECAST
16.3.3 UK: MARKET SIZE & FORECAST
16.3.4 GERMANY: MARKET SIZE & FORECAST
16.3.5 ITALY: MARKET SIZE & FORECAST
17 CENTRAL, EASTERN & SOUTHERN EUROPE
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 KEY COUNTRIES
17.3.1 NETHERLANDS: MARKET SIZE & FORECAST
17.3.2 PORTUGAL: MARKET SIZE & FORECAST
17.3.3 SWITZERLAND: MARKET SIZE & FORECAST
18 NORDICS
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 KEY COUNTRIES
18.3.1 SWEDEN: MARKET SIZE & FORECAST
18.3.2 DENMARK: MARKET SIZE & FORECAST
19 COMPETITIVE LANDSCAPE
19.1 COMPETITION OVERVIEW
19.2 MARKET SHARE ANALYSIS
19.2.1 F. HOFFMANN-LA ROCHE
19.2.2 QIAGEN
20 KEY COMPANY PROFILES
20.1 F. HOFFMANN-LA ROCHE
20.1.1 BUSINESS OVERVIEW
20.1.2 PRODUCT OFFERINGS
20.1.3 KEY STRATEGIES
20.1.4 KEY STRENGTHS
20.1.5 KEY OPPORTUNITIES
20.2 QIAGEN
21 OTHER PROMINENT VENDORS
21.1 ALTONA DIAGNOSTICS
21.1.1 BUSINESS OVERVIEW
21.1.2 PRODUCT OFFERINGS
21.2 AUTOBIO
21.3 APPLIED DNA SCIENCES
21.4 AURORA BIOMED
21.5 BIOACTIVA DIAGNOSTICA
21.6 BEIJING HOTGEN BIOTECH
21.7 BIOGX
21.8 CERTEST BIOTEC
21.9 CREATIVE BIOGENE
21.10 CORDX
21.11 CLONIT
21.12 EUROBIO SCIENTIFIC
21.13 FIREGENE
21.14 GENSCRIPT
21.15 GUANGZHOU PLUSLIFE BIOTECH
21.16 JOYSBIO (TIANJIN) BIOTECHNOLOGY
21.17 NANJING SYNTHGENE MEDICAL TECHNOLOGY
21.18 RAYBIOTECH LIFE
21.20 VIRAX BIOLABS
21.21 WONDFO
21.22 SHANGHAI BIOGERM MEDICAL TECHNOLOGY
22 REPORT SUMMARY
22.1 KEY TAKEAWAYS
22.2 STRATEGIC RECOMMENDATIONS
23 QUANTITATIVE SUMMARY
23.1 MARKET BY GEOGRAPHY
23.2 MARKET BY TYPE
23.3 MARKET BY END-USER
24 APPENDIX
24.1 ABBREVIATIONS
About
Us
:
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.
Click Here to Contact Us
Call: +1-312-235-2040
+1 302 469 0707
Mail: [email protected]
Photo: https://mma.prnewswire.com/media/1999263/Europe_Monkey_Pox_Market.jpg
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg
SOURCE Arizton Advisory & Intelligence
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.